global rotator cuff biological mesh market size was valued at USD 138 million in 2024. The market is projected to grow from USD 148 million in 2025 to USD 230 million by 2032, exhibiting a CAGR of 7.7% during the forecast period.
Drivers - Rising Prevalence of Shoulder Injuries to Fuel Market Expansion
Restraints - High Treatment Costs Limiting Market Penetration
Opportunities -Integration With Regenerative Medicine Creating New Growth Avenues
North America dominates the Rotator Cuff Biological Mesh market, accounting for over 40% of global revenue as of 2024.
Europe’s market growth is shaped by rising geriatric populations (22% aged 65+ as of 2023) and robust healthcare infrastructure favoring biologics over synthetic implants.
• Human Dermal Allografts
• Xenografts
• Synthetic-Biologic Hybrid Mesh
• Others
• Partial-Thickness Rotator Cuff Tears
• Full-Thickness Rotator Cuff Tears
• Massive/Irreparable Rotator Cuff Tears
￭Shanghai PINE&POWER Biotech (China)
￭Eyebright Medical Technology (Beijing) Co., Ltd. (China)
￭Arthrex, Inc. (U.S.)
￭CONMED Corporation (U.S.)
￭Stryker Corporation (U.S.)
￭Zimmer Biomet Holdings, Inc. (U.S.)
￭Smith & Nephew plc (U.K.)
Established ourselves in the year 2015, Intel Market Reports is a popular market research company that provides an in-depth quantified market research report. The Purpose - To deliver effective and fruit-bearing market research reports. Our portfolio includes the list of 30+ companies belonging to the Fortune 500 list. We have achieved this milestone in less than half a decade.
